Effects of Honokiol on sepsis-induced acute kidney injury in an experimental model of sepsis in rats

Inflammation

Volumn 37, Issue 4, 2014, Pages 1191-1199

  Li, Nan ^a   Xie, Hua ^a   Li, Longkai ^a   Wang, Jing ^a   Fang, Ming ^a   Yang, Ning ^a   Lin, Hongli ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

acute kidney injury; honokiol; inflammation; oxidative stress; sepsis

Indexed keywords

HONOKIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; BIPHENYL DERIVATIVE; CYTOKINE; LIGNAN; NITRIC OXIDE; NOS2 PROTEIN, RAT;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; KIDNEY PARENCHYMA; MALE; NONHUMAN; OXIDATIVE STRESS; PERIODIC ACID SCHIFF STAIN; PROTEIN EXPRESSION; RAT; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL; TISSUE STRUCTURE; WESTERN BLOTTING; ACUTE KIDNEY INJURY; ANIMAL; COMPLICATION; DISEASE MODEL; INFLAMMATION; KIDNEY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

MAGNOLIA OFFICINALIS; RATTUS;

ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION; KIDNEY; LIGNANS; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84904748968     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9845-x     Document Type: Article

References (55)

1. Bone, R.C., C.L. Sprung, and W.J. Sibbald. 1992. Definitions for sepsis and organ failure. Critical Care Medicine 20: 724-726.
2. Zarjou, A., and A. Agarwal. 2011. Sepsis and acute kidney injury. Journal of the American Society of Nephrology 22: 999-1006. doi:10.1681/ASN.2010050484.
3. Goncalves, G.M., D.S. Zamboni, and N.O. Camara. 2010. The role of innate immunity in septic acute kidney injuries. Shock 34(Suppl 1): 22-26. doi:10.1097/SHK.0b013e3181e7e69e.
4. Hocherl, K., C. Schmidt, B. Kurt, and M. Bucher. 2010. Inhibition of NF-kappaB ameliorates sepsis-induced downregulation of aquaporin-2/V2 receptor expression and acute renal failure in vivo. American Journal of Physiology. Renal Physiology 298: F196-F204. doi:10.1152/ajprenal.90607.2008.
5. Lopes, J.A., P. Fernandes, S. Jorge, C. Resina, C. Santos, A. Pereira, J. Neves, F. Antunes, and A. Gomes da Costa. 2010. Long-term risk of mortality after acute kidney injury in patients with sepsis: a contemporary analysis. BMC Nephrology 11: 9. doi:10.1186/1471-2369-11-9.
6. Bagshaw, S.M., S. Uchino, R. Bellomo, H. Morimatsu, S. Morgera, M. Schetz, I. Tan, C. Bouman, E. Macedo, N. Gibney, A. Tolwani, H.M. Oudemans-van Straaten, C. Ronco, and J.A. Kellum. 2007. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clinical Journal of the American Society of Nephrology 2: 431-439. doi:10.2215/CJN.03681106.
7. Doi, K., A. Leelahavanichkul, P.S. Yuen, and R.A. Star. 2009. Animal models of sepsis and sepsis-induced kidney injury. Journal of Clinical Investigation 119: 2868-2878. doi:10.1172/JCI39421.
8. Liou, K.T., S.M. Lin, S.S. Huang, C.L. Chih, and S.K. Tsai. 2003. Honokiol ameliorates cerebral infarction from ischemia-reperfusion injury in rats. Planta Medica 69: 130-134. doi:10.1055/s-2003-37707.
9. Arora, S., S. Singh, G.A. Piazza, C.M. Contreras, J. Panyam, and A.P. Singh. 2012. Honokiol: a novel natural agent for cancer prevention and therapy. Current Molecular Medicine 12: 1244-1252.
10. Kim, B.H., and J.Y. Cho. 2008. Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression. Acta Pharmacologica Sinica 29: 113 - 122. doi:10.1111/j.1745-7254.2008.00725.x.
11. Wang, Y., Z.Z. Zhang, Y. Wu, J. Zhan, X.H. He, and Y.L. Wang. 2013. Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation. Experimental and Therapeutic Medicine 5: 315-319. doi:10.3892/etm.2012.766.
12. Lo, Y.C., C.M. Teng, C.F. Chen, C.C. Chen, and C.Y. Hong. 1994. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochemical Pharmacology 47: 549-553.
13. Dikalov, S., T. Losik, and J.L. Arbiser. 2008. Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochemical Pharmacology 76: 589-596. doi:10.1016/j.bcp.2008.06.012.
14. Fried, L.E., and J.L. Arbiser. 2009. Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxidants and Redox Signaling 11: 1139-1148. doi:10.1089/ARS.2009.2440.
15. Li, Z., Y. Liu, X. Zhao, X. Pan, R. Yin, C. Huang, L. Chen, and Y. Wei. 2008. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. European Journal of Obstetrics, Gynecology, and Reproductive Biology 140: 95-102. doi:10.1016/j.ejogrb.2008.02.023.
16. Liu, H., C. Zang, A. Emde, M.D. Planas-Silva, M. Rosche, A. Kuhnl, C.O. Schulz, E. Elstner, K. Possinger, and J. Eucker. 2008. Antitumor effect of honokiol alone and in combination with other anticancer agents in breast cancer. European Journal of Pharmacology 591: 43-51. doi:10.1016/j.ejphar.2008.06.026.
17. Bai, X., F. Cerimele, M. Ushio-Fukai, M. Waqas, P.M. Campbell, B. Govindarajan, C.J. Der, T. Battle, D.A. Frank, K. Ye, E. Murad, W. Dubiel, G. Soff, and J.L. Arbiser. 2003. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. Journal of Biological Chemistry 278: 35501-35507. doi:10.1074/jbc.M302967200. (Pubitemid 37102321)
18. Wu, F., W. Zhang, L. Li, F. Zheng, X. Shao, J. Zhou, and H. Li. 2011. Inhibitory effects of honokiol on lipopolysaccharide-induced cellular responses and signaling events in human renal mesangial cells. European Journal of Pharmacology 654: 117-121. doi:10.1016/j.ejphar.2010.11.022.
19. Wu, J.P., W. Zhang, F. Wu, Y. Zhao, L.F. Cheng, J.J. Xie, and H.P. Yao. 2010. Honokiol: an effective inhibitor of high-glucose-induced upregulation of inflammatory cytokine production in human renal mesangial cells. Inflammation Research 59: 1073-1079. doi:10.1007/s00011-010-0227-z.
20. Chiang, C.K., M.L. Sheu, Y.W. Lin, C.T. Wu, C.C. Yang, M.W. Chen, K.Y. Hung, K.D. Wu, and S.H. Liu. 2011. Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro. British Journal of Pharmacology 163: 586-597. doi:10.1111/j.1476-5381. 2011.01242.x.
21. Weng, T.I., H.Y. Wu, C.W. Kuo, and S.H. Liu. 2011. Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation. Intensive Care Medicine 37: 533-541. doi:10.1007/s00134-010-2104-1.
22. Souza, A.C., R.A. Volpini, M.H. Shimizu, T.R. Sanches, N.O. Camara, P. Semedo, C.E. Rodrigues, A.C. Seguro, and L. Andrade. Erythropoietin prevents sepsis-related acute kidney injury in rats by inhibiting NF-kappaB and upregulating endothelial nitric oxide synthase. American Journal of Physiology. Renal Physiology 302: F1045-F1054. doi:10.1152/ajprenal.00148.2011.
23. Hu, Y.M., M.H. Pai, C.L. Yeh, Y.C. Hou, and S.L. Yeh. 2012. Glutamine administration ameliorates sepsis-induced kidney injury by downregulating the high-mobility group box protein-1-mediated pathway in mice. American Journal of Physiology. Renal Physiology 302: F150-F158. doi:10.1152/ajprenal.00246.2011.
24. Galley, H.F. 2011. Oxidative stress and mitochondrial dysfunction in sepsis. British Journal of Anaesthesia 107: 57-64. doi:10.1093/bja/aer093.
25. Huet, O., L. Dupic, A. Harrois, and J. Duranteau. 2011. Oxidative stress and endothelial dysfunction during sepsis. Frontiers in Bioscience (Landmark edition) 16: 1986-1995.
26. Pascual-Guardia, S., F. Arbol, E. Sanchez, C. Casadevall, V. Merlo, J. Gea, and E. Barreiro. 2013. Inflammation and oxidative stress in respiratory and limb muscles of patients with severe sepsis. Medicina Clínica (Barcelona) 141: 194-200. doi:10.1016/j.medcli.2012.05.026.
27. Dirkes, S. 2013. Sepsis and inflammation: impact on acute kidney injury. Nephrology Nursing Journal 40: 125-132. quiz 133.
28. Doughty, L.A., S.S. Kaplan, and J.A. Carcillo. 1996. Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Critical Care Medicine 24: 1137-1143. (Pubitemid 26249363)
29. Kirkeboen, K.A., and O.A. Strand. 1999. The role of nitric oxide in sepsis - an overview. Acta Anaesthesiologica Scandinavica 43: 275-288. (Pubitemid 29109473)
30. Chandra, A., P. Enkhbaatar, Y. Nakano, L.D. Traber, and D.L. Traber. 2006. Sepsis: emerging role of nitric oxide and selectins. Clinics (São Paulo, Brazil) 61: 71-76.
31. DiDonato, J.A., F. Mercurio, and M. Karin. 2012. NF-kappaB and the link between inflammation and cancer. Immunology Reviews 246: 379-400. doi:10.1111/j.1600-065X.2012.01099.x.
32. Ghosh, S., and M.S. Hayden. 2008. New regulators of NF-kappaB in inflammation. Nature Reviews Immunology 8: 837-848. doi:10.1038/nri2423.
33. Doi, K., X. Hu, P.S. Yuen, A. Leelahavanichkul, H. Yasuda, S.M. Kim, J. Schnermann, T.E. Jonassen, J. Frokiaer, S. Nielsen, and R.A. Star. 2008. AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney International 73: 1266-1274. doi:10.1038/ki.2008.97. (Pubitemid 351693164)
34. Gerretsen, G., H.J. Huisjes, and J.D. Elema. 1981. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. British Journal of Obstetrics and Gynaecology 88: 876-881. (Pubitemid 11018178)
35. Hull, J.H., L.J. Hak, G.G. Koch, W.A. Wargin, S.L. Chi, and A.M. Mattocks. 1981. Influence of range of renal function and liver disease on predictability of creatinine clearance. Clinical Pharmacology and Therapeutics 29: 516-521. (Pubitemid 11039806)
36. Cockcroft, D.W., and M.H. Gault. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
37. Toto, R.D. 1995. Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance. Current Opinion in Nephrology and Hypertension 4: 505-509. discussion 503-4.
38. Chvojka, J., R. Sykora, T. Karvunidis, J. Radej, A. Krouzecky, I. Novak, and M. Matejovic. 2010. New developments in septic acute kidney injury. Physiological Research 59: 859-869.
39. Lentini, P., M. de Cal, D. Cruz, A. Chronopoulos, S. Soni, F. Nalesso, M. Zanella, F. Garzotto, A. Brendolan, P. Piccinni, and C. Ronco. The role of advanced oxidation protein products in intensive care unit patients with acute kidney injury. Journal of Critical Care 25: 605-609. doi:10.1016/j.jcrc.2010.04. 006.
40. Pinto, C.F., Watanabe, M., da Fonseca, C.D., Ogata, C.I., and Vattimo Mde, F. 2012. The sepsis as cause of acute kidney injury: an experimental model. Rev Esc Enferm USP 46 Spec No: 86-90. doi: 10.1590/S0080-62342012000700013.
41. Fortin, C.F., P.P. McDonald, T. Fulop, and O. Lesur. 2010. Sepsis, leukocytes, and nitric oxide (NO): an intricate affair. Shock 33: 344-352. doi:10.1097/SHK.0b013e3181c0f068.
42. Aksu, U., C. Demirci, and C. Ince. 2011. The pathogenesis of acute kidney injury and the toxic triangle of oxygen, reactive oxygen species and nitric oxide. Contributions to Nephrology 174: 119-128. doi:10.1159/000329249.
43. Pacher, P., J.S. Beckman, and L. Liaudet. 2007. Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 87: 315-424. doi:10.1152/physrev.00029.2006. (Pubitemid 46217686)
44. Anderson, R.J. 2012. Acute kidney injury with sepsis: is nitric oxide a friend, foe, both, or neither? Critical Care Medicine 40: 2511-2512. doi:10.1097/CCM.0b013e318255d7b4.
45. Hauser, B., H. Bracht, M. Matejovic, P. Radermacher, and B. Venkatesh. 2005. Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies. Anesthesia and Analgesia 101: 488-498. doi:10.1213/01.ANE.0000177117.80058.4D. (Pubitemid 41045235)
46. Singh, T., and S.K. Katiyar. 2011. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2. International Journal of Oncology 38: 769-776. doi:10.3892/ijo.2011.899.
47. Hu, Z., X. Bian, X. Liu, Y. Zhu, X. Zhang, S. Chen, K. Wang, and Y. Wang. 2013. Honokiol protects brain against ischemia-reperfusion injury in rats through disrupting PSD95-nNOS interaction. Brain Research 1491: 204 - 212. doi:10.1016/j.brainres.2012.11.004.
48. Weng, T.I., H.Y. Wu, B.L. Chen, and S.H. Liu. 2012. Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis. Shock 37: 478-484. doi:10.1097/SHK.0b013e31824653be.
49. Hotchkiss, R.S., and I.E. Karl. 2003. The pathophysiology and treatment of sepsis. New England Journal of Medicine 348: 138-150. doi:10.1056/ NEJMra021333. (Pubitemid 36056721)
50. Fang, J.P., Y. Liu, J. Li, W.F. Liao, Y.H. Hu, and K. Ding. 2012. A novel small molecule, HK-156, inhibits lipopolysaccharide-induced activation of NF-kappaB signaling and improves survival in mouse models of sepsis. Acta Pharmacologica Sinica 33: 1204-1216. doi:10.1038/aps.2012.56.
51. O'Sullivan, A.W., J.H. Wang, and H.P. Redmond. 2009. NF-kappaB and p38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy. Journal of Surgical Research 152: 46-53. doi:10.1016/j.jss.2008.04.030.
52. Zhang, P., X. Liu, Y. Zhu, S. Chen, D. Zhou, and Y. Wang. 2013. Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-kappaB activation and cytokine production of glial cells. Neuroscience Letters 534: 123-127. doi:10.1016/j.neulet.2012.11.052.
53. Zhu, X., Z. Wang, C. Hu, Z. Li, and J. Hu. 2013. Honokiol suppresses TNF-alpha-induced migration and matrix metalloproteinase expression by blocking NF-kappaB activation via the ERK signaling pathway in rat aortic smooth muscle cells. Acta Histochemica. doi:10.1016/j.acthis.2013.11.005.
54. Hoffmann, A., A. Levchenko, M.L. Scott, and D. Baltimore. 2002. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298: 1241-1245. doi:10.1126/science.1071914. (Pubitemid 35285493)
55. Scheidereit, C. 2006. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25: 6685-6705. doi:10.1038/sj.onc. 1209934. (Pubitemid 44657846)